Laboratory of Cancer Genetics, Department of Pathology, Institute of Polish Mother's Memorial Hospital, Rzgowska 281/289, 93-338, Lodz, Poland.
Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-237, Lodz, Poland.
Pathol Oncol Res. 2019 Oct;25(4):1311-1317. doi: 10.1007/s12253-017-0370-8. Epub 2017 Dec 5.
Single nucleotide polymorphisms (SNPs) may modify the risk of cancer. They may be then regarded as potential markers of carcinogenesis. The aim of this study was to analyze the frequency of genotypes and alleles of SNPs in DNA repair genes and to investigate the influence this genetic variation exerts on breast cancer in Polish females. The test group comprised 600 females with breast cancer and 600 healthy controls. Genomic DNA was isolated and the SNPs in DNA repair genes were determined by High-Resolution Melter (HRM) technique. Following polymorphisms were analysed: Arg399Gln (rs25487) of the XRCC1, Gly322Asp (rs4987188) of the hMSH2, Lys751Gln (rs13181) of the XPD, Arg188His (rs3218536) of the XRCC2, P871L (rs799917) of the BRCA1 and N372H (rs144848) of the BRCA2 gene. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each genotype and allele. Statistically significant correlations were identified between 4 single nucleotide polymorphisms and the breast cancer risk: rs25487 rs4987188 rs13181 and rs799917. The alleles XRCC1-Gln (OR 5.11; 95% CI 5.68-11.64, p < .0001), hMSH2-Asp (OR 4.66; 95% CI 3.90-5.56, p < .0001), XPD-Gln (OR 2.65; 95% CI 2.24-3.14, p < .0001) and BRCA1-L (OR 1.45; 95% CI 1.24-1.71, p < .0001) genes were strongly correlated with this malignancy. No correlation was found between the studied SNPs and tumor grading nor the lymph node status. Further research on larger groups is warranted to determine the influence of above-mentioned genetic variants on breast cancer risk.
单核苷酸多态性(SNPs)可能会改变癌症的风险。因此,它们可以被视为致癌作用的潜在标志物。本研究的目的是分析 DNA 修复基因中 SNPs 的基因型和等位基因频率,并研究这种遗传变异对波兰女性乳腺癌的影响。实验组包括 600 名乳腺癌女性和 600 名健康对照者。提取基因组 DNA,采用高分辨率熔解(HRM)技术检测 DNA 修复基因中的 SNPs。分析了以下多态性:XRCC1 的 Arg399Gln(rs25487)、hMSH2 的 Gly322Asp(rs4987188)、XPD 的 Lys751Gln(rs13181)、XRCC2 的 Arg188His(rs3218536)、BRCA1 的 P871L(rs799917)和 BRCA2 的 N372H(rs144848)。计算每个基因型和等位基因的优势比(OR)和 95%置信区间(CI)。鉴定出 4 个单核苷酸多态性与乳腺癌风险之间存在统计学显著相关性:rs25487、rs4987188、rs13181 和 rs799917。XRCC1-Gln 等位基因(OR 5.11;95%CI 5.68-11.64,p<.0001)、hMSH2-Asp(OR 4.66;95%CI 3.90-5.56,p<.0001)、XPD-Gln(OR 2.65;95%CI 2.24-3.14,p<.0001)和 BRCA1-L(OR 1.45;95%CI 1.24-1.71,p<.0001)等位基因与这种恶性肿瘤密切相关。研究 SNPs 与肿瘤分级或淋巴结状态之间无相关性。需要对更大的研究群体进行进一步研究,以确定上述遗传变异对乳腺癌风险的影响。